1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC
(
- Contribution to journal › Article
- 2017
-
Mark
Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
(
- Contribution to journal › Article
- 2016
-
Mark
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Profiling cancer testis antigens in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2015
-
Mark
LRIG1 is a prognostic biomarker in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.
(
- Contribution to journal › Article
- 2014
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status.
(
- Contribution to journal › Article
- 2012
-
Mark
CD99 is a novel prognostic stromal marker in non-small cell lung cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer.
(
- Contribution to journal › Article